'Intuitive Surgical' CMO Sells $1.5 Billion Stake Amid Expansion of Direct Sales in Europe

Intuitive Surgical, Inc. (NASDAQ: ISRG) Chief Medical Officer Mariam Curet sold approximately 2,300 shares of company stock on February 27 under a pre-established Rule 10b5-1 trading plan via a trust, generating roughly $1.17 million in proceeds (about 1.5 billion KRW). On February 10–11 and 28, a large number of restricted stock units (RSUs) and performance shares vested and converted into common stock, with some shares returned to the company for tax withholding. As a result, the trust’s holdings surged from a few hundred shares to more than 5,000 shares during that period. The company disclosed that the issuance of RSUs and performance shares and the related tax withholding are routine compensation and tax procedures, and that the February 27 open-market sale was a separate disposition at the insider’s discretion.

On March 2, Intuitive announced that it had acquired the distribution businesses for its da Vinci and Ion systems from its European partners ab medica, Abex, and Excelencia Robótica, transitioning to a direct-sales model in key Southern European countries including Italy, Spain, Portugal, Malta, and San Marino. The transaction adds approximately 250 employees to Intuitive’s European operations, and, as of year-end 2025, the company will directly handle sales, marketing, and customer support for more than 470 da Vinci surgical systems installed in the region.

In its January 22 release of fourth-quarter 2025 results, Intuitive confirmed its growth momentum by exceeding market expectations for both revenue and earnings per share. In February, the stock continued to trade on relatively high volumes amid strong performance and news of its European expansion. Some market analysts view the Southern Europe distribution network acquisition as a strategic move into a regional robotic surgery market projected to grow at a double-digit annual rate.

Headquartered in California, Intuitive Surgical is a leading developer, manufacturer, and seller of robotic surgical equipment, best known for its minimally invasive da Vinci surgical systems. The company supplies robotic systems to hospitals and has built a recurring-revenue model based on consumables and service sales, expanding installations across a global network of major hospitals, including those in Europe.